期刊文献+

多囊卵巢综合征不孕症患者性激素与腹部脂肪厚度的相关性研究 被引量:5

Correlation between Sex Hormones and Abdominal Fat Thickness in Infertility Women with Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的探讨多囊卵巢综合征(PCOS)不孕症患者性激素与腹部脂肪厚度的相关性,为临床治疗提供依据。方法 166例PCOS不孕症患者,于月经期检测性激素,并超声检测腹部及皮下脂肪厚度,对上述各项检测指标进行相关性分析。结果 PCOS不孕症患者的促卵泡生成素(FSH)、促黄体生成素(LH)与肝前皮下脂肪厚度及腹部皮下脂肪厚度均呈负相关(P﹤0.05);雌二醇(E2)与肝前皮下脂肪厚度呈负相关(P﹤0.05);睾酮与腹部皮下脂肪厚度呈正相关(P﹤0.05);泌乳素(PRL)则与腹部脂肪厚度无明显相关关系(P>0.05)。结论 PCOS不孕症患者部分性激素与腹腔内及皮下脂肪厚度有关,在临床诊治时应综合考虑多方因素。 Objective To study the correlation between sex hormones and abdominal fat thickness in infertility women with polycystic ovary syndrome(PCOS),and to provide a basis for treatment of infertility women with PCOS.Methods One hundred and sixty-six infertility women with PCOS were enrolled in the study.Their serum sex hormones was detected during menstrual period while abdominal and subcutaneous fat thickness were detected by ultrasound,and a correlation analysis of the indicators above was performed.Results FSH,LH negatively correlated with liver subcutaneous fat thickness and abdominal subcutaneous fat thickness in infertility women with PCOS(P 0.05);There was a negative correlation between E2 and liver subcutaneous fat thickness(P 0.05);And there was a positive correlation between testosterone and abdominal subcutaneous fat thickness(P 0.05);No significant correlation was found between PRL and abdominal fat thickness(P 0.05).Conclusion For some sex hormones correlate with intraabdominal and subcutaneous fat thickness in infertility women with PCOS,various factors should be considered in the clinical diagnosis and treatment of such patients.
出处 《广西医学》 CAS 2013年第9期1135-1137,共3页 Guangxi Medical Journal
基金 广西科学研究与技术开发计划项目(10124001A-52)
关键词 多囊卵巢综合征 性激素 腹部脂肪 超声诊断 Polycystic ovary syndrome Sex hormone Abdominal fat Ultrasound
  • 相关文献

参考文献12

  • 1乐杰.妇产科学[M].第6版.北京:人民卫生出版社,2005.262.
  • 2Yildirim B,Sabir N,Kaleli B.Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with palycystic ovary syndrome [J].Fertil Steril,2003,79(6):1 358-1 364.
  • 3Cascella T,Palomba S,De Sio I,et al.Visceral fat is associ-ated with cardiovascular risk in women with polycystic ovary syndrome[J].Hum Reprod,2008,23(1):153-159.
  • 4Gotoh H,Gohda T,Tanimoto M,et al.Contribution of subcutaneous fat accumulation to insulin resistance and athero-sclerosis in haemodialysis patients [J].Nephrol Dial Transplant,2009,24(11):3 474-3 480.
  • 5Rotterdam ESHRE/ASRM-Spongsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and IonG-term health risks related to polycystic ovary syndrome(PCOS)[J].Hum Reprod,2004,19(I):41-47.
  • 6疋田稔,曲成业.肥胖[J].日本医学介绍,2001,22(7):302-303. 被引量:9
  • 7Apridonidze T,Essah P,Luomo M,et al.Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].J Clin Endocrinol Metab,2005,90(4):1 929-1 935.
  • 8梁晨,李威,吴效科.女性腹型肥胖与多囊卵巢综合征[J].医学研究杂志,2010,39(8):113-115. 被引量:12
  • 9Ribeiro-Filho FF,Faria AN,Azjen S,et al.Methods of estimation of visceral fat:advantages of ultrasonography [J].Obes Res,2003,11(12):1 488-1 494.
  • 10Kim SK,Kim HJ,Hur KY,et al Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic disea-ses[J].Am J Clin Nutr,2004,79(4):593-599.

二级参考文献38

  • 1朱翠凤,卞苏环,刘颜,叶敏,陈恒娇,韩巍,吴远,张献共.腰臀比值和体质指数在风险预测代谢综合征的应用研究[J].中国全科医学,2006,9(17):1411-1413. 被引量:14
  • 2Azziz R,et al.The prevalence and features of the polycystic ovary syndrome in an unselected population.J Clin Endocrinol.Metab,2004,89(6):2745-2749.
  • 3Wickenheisser J K,et al.Human ovarian theca cells in culture.Trends Endocrinol.Metab,2006,17(2):65-71.
  • 4Escobar-Morreale H F,et al.The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.Endocr Rev,2005,26(2):251-282.
  • 5Alvarez-Blasco F,et al.Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.Arch Intern Med,2006,166(19):2081-2086.
  • 6Lo J C,et al.Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome:a population-based study.Diabetes Care,2006,29(8):1915-1917.
  • 7Peppard,H R,et al.Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.Diabetes Care,2001,24(6):1050-1052.
  • 8Musso C,et al.Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes):a 30-year prospective.Medicine (Baltimore),2004,83(4):209-222.
  • 9Stanciu I N,et al.Insulinoma presenting with hyperandrogenism:a case report and a literature review.J Intern Med,2003,253(4):484-489.
  • 10Codner E and Escobar-Morreale H F.Hyperandrogenism and polycystic ovary syndrome (PCOS) in women with type 1 diabetes Mellitus.J Clin Endocrinol Metab,2007,92(4):1209-1216.

共引文献734

同被引文献75

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部